- Atopic dermatitis is a common skin condition with unknown causes. Allergic contact dermatitis is related to exposure to certain substances that trigger an allergic reaction.
- Research is ongoing about how atopic dermatitis may be related to other skin conditions.
- A new study found evidence that children with atopic dermatitis may be more at risk for allergic contact dermatitis.
- The results point to the usefulness of follow-up testing among children with atopic dermatitis so that doctors can determine the best course of treatment.
Atopic dermatitis, more commonly called eczema, is an unpleasant skin condition common among children.
While this may be the primary skin problem occurring, recent evidence suggests that there may be more to the story.
A study published in the Journal of the American Academy of Dermatology examined more than 900 children with and without atopic dermatitis.
The researchers reported that children who already had atopic dermatitis were more likely to have allergic contact dermatitis as well.
They said the study’s results indicate that children diagnosed with atopic dermatitis may benefit from further clinical testing to identify other skin sensitivities that may be present.
People with atopic dermatitis often have red, itchy patches of skin that can appear in various locations. The skin condition can worsen when people scratch or pick at the skin. The precise cause of atopic dermatitis is unknown.
In patch testing, a dermatologist will put small amounts of substances that could cause an allergic reaction on the skin and put a patch over the area. Based on the reaction, doctors can determine the cause so people can avoid that particular substance.
Sometimes, it can be challenging for doctors to distinguish between atopic and allergic contact dermatitis.
Dr. India Hill, a pediatric dermatologist at Children’s Hospital New Orleans who was not involved in the study, explained to Medical News Today:
“Atopic dermatitis is a chronic inflammatory skin disease influenced by both innate and external factors. Allergic contact dermatitis is a reproducible delayed type 4 hypersensitivity reaction to a specific allergen. Though these two conditions may occur in the same individual, they each have distinct underlying pathophysiology. The two conditions may be difficult to distinguish clinically because they share similar morphologic findings.”
Researchers of the current study wanted to look more into the relationship between having atopic dermatitis and allergic contact dermatitis. They also wanted to see if children with atopic dermatitis were more likely to have reactions to specific allergens.
This study was a retrospective case-control study. Researchers included 912 children in their data collection. Of the children they included in the study, 615 of the children had atopic dermatitis and 297 did not have atopic dermatitis. These children had been referred for patch testing between 2018 and 2022.
Researchers reported that children with atopic dermatitis were more likely to have seen more providers before they underwent patch testing.
Researchers said that the children with atopic dermatitis “were more likely to have more than one positive reaction.” They also found that the children with atopic dermatitis were more likely to experience positive test results than children without atopic dermatitis.
They further reported that children with atopic dermatitis were more likely to experience an allergic response to certain substances, including bacitracin, carba mix, and cocamidopropyl betaine.
Researchers noted that children with atopic dermatitis may have increased exposure to these substances. For example, bacitracin is part of many common over-the-counter topical antibiotics and cocamidopropyl betaine is part of more gentle skin care products.
Dr. Dustin Portela, an osteopathic physician specializing in dermatology who was not involved in the study, commented on the study to Medical News Today:
“This study reveals that allergic contact dermatitis (ACD) may be under-diagnosed in our patients with AD [atopic dermatitis]. Although AD tends to make its first appearance at younger ages than ACD, these patients are more likely to develop contact allergies due to their compromised skin barrier and activated immune system. If we can more frequently identify which AD patients have concomitant ACD we can help those patients avoid their allergens and improve their disease symptoms more effectively. This should allow us to decrease those children’s exposure to topical corticosteroids.”
This research does have certain limitations.
First, it cannot establish that having one particular type of dermatitis causes another type of dermatitis.
Researchers note that there may have been technical variables that influenced patch-testing outcomes since different centers performed the testing.
Interpretation of test results and diagnosis may not have been accurate in every case, so there may have been misclassification bias.
There was also the possibility of selection bias.
In addition, most of the children included in the study were white girls, so the results might not apply to other populations.
Finally, researchers were limited by reliance on patient reporting, which is not always accurate for certain data collection components such as how long a child had had atopic dermatitis and how many previous providers the child had seen.
Researchers did not have access to participants’ medical records, so they could not confirm atopic dermatitis diagnoses or participants’ medical history.
Regardless of these limitations, experts say the results indicate the potential benefits of patch testing among children with atopic dermatitis.
Dr. Amelia Damse, an osteopathic physician specializing in dermatology and practicing at Oceans Dermatology in Florida who was not involved in the study, noted the following clinical implications to Medical News Today:
“The study’s data carries substantial clinical implications for dermatologists managing pediatric patients with atopic dermatitis. The heightened patch test reactivity suggests a need for increased vigilance in selecting skincare products, emphasizing the importance of hypoallergenic formulations. Clinicians should be attuned to potential sensitivities, particularly towards commonly used allergens like cocamidopropyl betaine and bacitracin. This underscores the necessity for personalized skincare regimens, with a focus on minimizing allergen exposure.”